Obesity is associated with visit-to-visit systolic blood pressure variability in the US adults

Journal of Public Health (United Kingdom)

Volumn 37, Issue 4, 2015, Pages 694-700

  Faramawi, Mohammed F ^a,b   Fischbach, Lori ^a   Delongchamp, Robert ^a   Cardenas, Victor ^a   Abouelenien, Saly ^a   Chedjieu, Irene P ^a   Taha, Noha ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b MENOUFIA UNIVERSITY   (Egypt)

^c Cairo University   (Egypt)

Author keywords

Blood pressure; Epidemiology; Obesity; Population based and preventative services

Indexed keywords

ADULT; AMBULATORY CARE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; MALE; OBESITY; UNITED STATES;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; OBESITY; OFFICE VISITS; UNITED STATES;

EID: 84985945495     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdu098     Document Type: Article

References (38)

1. Perkovic V, Huxley R, Wu Y et al. The burden of blood pressure-related disease: a neglected priority for global health. Hypertension 2007;50:991-7.
2. Moser M, Basile J, Cushman W. Hypertension, renal disease, and cardiovascular outcomes. J Clin Hypertens 2005;7:479-84.
3. Kotchen TA. The search for strategies to control hypertension. Circulation 2010;122:1141-3.
4. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303:2043-50.
5. Grassi G, Bombelli M, Brambilla G et al. Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications. Curr Hypertens Rep 2012;14:333-8.
6. Rossignol P, Kessler M, Zannad F. Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases. Curr Opin Nephrol Hypertens 2013;22:59-64.
7. Parati G, Ochoa JE, Lombardi C et al. Assessment and management of blood-pressure variability. Nat Rev Cardiol 2013;10:143-55.
8. Parati G, Ochoa JE, Salvi P et al. Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care 2013;36(Suppl. 2):S312-24.
9. Muntner P, Shimbo D, Tonelli M et al. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011;57:160-6.
10. Faramawi MF, Delongchamp R, Lin YS et al. Environmental lead exposure is associated with visit-to-visit systolic blood pressure variability in the US adults. Int Arch Occup Environ Health 2015;88:381-8.
11. Faramawi MF, Delongchamp R, Said Q et al. Metabolic syndrome is associated with visit-to-visit systolic blood pressure variability in the US adults. Hypertens Res 2014;37:875-9.
12. Stevens G, Singh G, Lu Y et al. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metrics 2012;10:22.
13. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health. Obes res 1998;6(Suppl. 2):51S-209S.
14. World Health Organization Consultation on Obesity. Obesity: Preventing and Managing the Global Epidemic. Geneva, Switzerland: Division of Noncommunicable Diseases, Programme of Nutrition, Family and Reproductive Health, World Health Organization, 1998.
15. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738.
16. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med 2002;162:2074-9.
17. Bozeman SR, Hoaglin DC, Burton TM et al. Predicting waist circumference from body mass index. BMC Med Res Methodol 2012;12:115.
18. Flegal KM, Carroll MD, Ogden CL et al. Prevalence and trends in obesity among us adults, 1999-2008. JAMA 2010;303:235-41.
19. Benowitz NL, Bernert JT, Caraballo RS et al. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol 2009;169:236-48.
20. Muntner P, Levitan EB. Visit-to-visit variability of blood pressure: current knowledge and future research directions. Blood Press Monit 2013;18:232-8.
21. Narkiewicz K. Obesity and hypertension-The issue is more complex than we thought. Nephrol Dial Transplant 2006;21:264-67.
22. Levitan EB, Kaciroti N, Oparil S et al. Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens 2013; 27:589-93.
23. Parati G, Stergiou GS, Asmar R et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008;26:1505-26.
24. Grassi G, Giannattasio C. Obesity and vascular stiffness: when body fat has an adverse impact on arterial dynamics. J Hypertens 2005;23: 1789-91.
25. Leopold JA. Cellular and molecular mechanisms of arterial stiffness associated with obesity. Hypertension 2013;62:1003-4.
26. Nordstrand N, Gjevestad E, Dinh KN et al. The relationship between various measures of obesity and arterial stiffness in morbidly obese patients. BMC cardiovasc Disord 2011;11:7.
27. Safar ME, Czernichow S, Blacher J. Obesity, arterial stiffness, and cardiovascular risk. J Am S Nephrol 2006;17:S109-11.
28. Selcuk A, Bulucu F, Kalafat F et al. Skinfold thickness as a predictor of arterial stiffness: obesity and fatness linked to higher stiffness measurements in hypertensive patients. Clin Exp Hypertens 2013;35: 459-64.
29. Tsioufis C, Tsiachris D, Stefanadis C. Abdominal obesity and arterial stiffness: the differential role of adipokines. Am J Hypertens 2010;23:457.
30. Zebekakis PE, Nawrot T, Thijs L et al. Obesity is associated with increased arterial stiffness from adolescence until old age. J Hypertens 2005;23:1839-46.
31. van den Bogaard B, Westerhof BE, van den Born B-JH. Prognostic significance of blood-pressure variability. Lancet 2010;376:413.
32. Diaz KM, Veerabhadrappa P, Kashem MA et al. Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in African Americans. Hypertens Res 2012;35:55-61.
33. Lind L, Berglund L, Larsson A et al. Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation 2011;123:1545-51.
34. Eguchi K, Hoshide S, Schwartz JE et al. Visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens 2012;25:962-8.
35. Muntner P, Joyce C, Levitan EB et al. Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care. J hypertens 2011;29:2332-8.
36. Hsieh YT, Tu ST, Cho TJ et al. Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5.5-year prospective analysis. Eur J Clin Invest 2012;42:245-53.
37. Levitan EB, Kaciroti N, Oparil S et al. Blood pressure measurement device, number and timing of visits, and intra-individual visit-to-visit variability of blood pressure. J Clin Hypertens 2012;14:744-50.
38. Skirton H, Chamberlain W, Lawson C et al. A systematic review of variability and reliability of manual and automated blood pressure readings. J Clin Nurs 2011;20:602-14.